RPT-BRIEF-Emergent Biosolutions to expand clinical trial of TRU-016 and rituximab

Fri Apr 5, 2013 7:17am EDT

April 5 (Reuters) - April 5 (Reuters) - Emergent Biosolutions Inc : * To expand front line CLL clinical trial of TRU-016 and rituximab based on strong patient enrollment and encouraging early clinical data * Source text for Eikon * Further company coverage

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.